CCA
RMD icon

Catalyst Capital Advisors’s ResMed RMD Stock Holding History

Catalyst Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-434
Closed -$119K – 445
2025
Q3 		$119K Sell
434
-19
-4% -$5.19K ﹤0.01% 290
2025
Q2 		$117K Buy
+453
New +$108K ﹤0.01% 310
2025
Q1 		– Sell
-363
Closed -$83K – 523
2024
Q4 		$83K Buy
+363
New +$87.4K ﹤0.01% 327
2014
Q3 		– Sell
-85,069
Closed -$4.31M – 473
2014
Q2 		$4.31M Buy
85,069
+15,402
+22% +$763K 0.7% 50
2014
Q1 		$3.11M Buy
+69,667
New +$3.13M 0.7% 52

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Catalyst Capital Advisors's RMD Position: Q4 2025 in Review

Catalyst Capital Advisors sold out of ResMed (RMD) in Q4 2025, closing a stake of 434 shares — an estimated $119K sold.

Catalyst Capital Advisors first reported a position in RMD in Q1 2014 and held it in 5 quarters. The position peaked at $4.31M in Q2 2014. 947 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Catalyst Capital Advisors reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Catalyst Capital Advisors sold 434 ResMed shares in Q4 2025, an estimated $119K.
  • Catalyst Capital Advisors first reported a position in ResMed in Q1 2014 and held it in 5 quarters.
  • Catalyst Capital Advisors's ResMed position peaked at $4.31M in Q2 2014.
  • 947 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Catalyst Capital Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.